Global Interventional Oncology Market Size, Status and Forecast 2024-2031

Report ID: 951111 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Interventional Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Ablation Devices
        1.2.3 Embolization Devices
        1.2.4 Support Devices
    1.3 Market by Application
        1.3.1 Global Interventional Oncology Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Liver Cancer
        1.3.3 Lung Cancer
        1.3.4 Kidney Cancer
        1.3.5 Bone Cancer
        1.3.6 Breast Cancer
        1.3.7 Prostate Cancer
        1.3.8 Pancreatic Cancer
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Interventional Oncology Market Perspective (2016-2027)
    2.2 Interventional Oncology Growth Trends by Regions
        2.2.1 Interventional Oncology Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Interventional Oncology Historic Market Share by Regions (2016-2021)
        2.2.3 Interventional Oncology Forecasted Market Size by Regions (2022-2027)
    2.3 Interventional Oncology Industry Dynamic
        2.3.1 Interventional Oncology Market Trends
        2.3.2 Interventional Oncology Market Drivers
        2.3.3 Interventional Oncology Market Challenges
        2.3.4 Interventional Oncology Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Interventional Oncology Players by Revenue
        3.1.1 Global Top Interventional Oncology Players by Revenue (2016-2021)
        3.1.2 Global Interventional Oncology Revenue Market Share by Players (2016-2021)
    3.2 Global Interventional Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Interventional Oncology Revenue
    3.4 Global Interventional Oncology Market Concentration Ratio
        3.4.1 Global Interventional Oncology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Revenue in 2020
    3.5 Interventional Oncology Key Players Head office and Area Served
    3.6 Key Players Interventional Oncology Product Solution and Service
    3.7 Date of Enter into Interventional Oncology Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Interventional Oncology Breakdown Data by Type
    4.1 Global Interventional Oncology Historic Market Size by Type (2016-2021)
    4.2 Global Interventional Oncology Forecasted Market Size by Type (2022-2027)

5 Interventional Oncology Breakdown Data by Application
    5.1 Global Interventional Oncology Historic Market Size by Application (2016-2021)
    5.2 Global Interventional Oncology Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Interventional Oncology Market Size (2016-2027)
    6.2 North America Interventional Oncology Market Size by Type
        6.2.1 North America Interventional Oncology Market Size by Type (2016-2021)
        6.2.2 North America Interventional Oncology Market Size by Type (2022-2027)
        6.2.3 North America Interventional Oncology Market Size by Type (2016-2027)
    6.3 North America Interventional Oncology Market Size by Application
        6.3.1 North America Interventional Oncology Market Size by Application (2016-2021)
        6.3.2 North America Interventional Oncology Market Size by Application (2022-2027)
        6.3.3 North America Interventional Oncology Market Size by Application (2016-2027)
    6.4 North America Interventional Oncology Market Size by Country
        6.4.1 North America Interventional Oncology Market Size by Country (2016-2021)
        6.4.2 North America Interventional Oncology Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Interventional Oncology Market Size (2016-2027)
    7.2 Europe Interventional Oncology Market Size by Type
        7.2.1 Europe Interventional Oncology Market Size by Type (2016-2021)
        7.2.2 Europe Interventional Oncology Market Size by Type (2022-2027)
        7.2.3 Europe Interventional Oncology Market Size by Type (2016-2027)
    7.3 Europe Interventional Oncology Market Size by Application
        7.3.1 Europe Interventional Oncology Market Size by Application (2016-2021)
        7.3.2 Europe Interventional Oncology Market Size by Application (2022-2027)
        7.3.3 Europe Interventional Oncology Market Size by Application (2016-2027)
    7.4 Europe Interventional Oncology Market Size by Country
        7.4.1 Europe Interventional Oncology Market Size by Country (2016-2021)
        7.4.2 Europe Interventional Oncology Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Interventional Oncology Market Size (2016-2027)
    8.2 Asia-Pacific Interventional Oncology Market Size by Type
        8.2.1 Asia-Pacific Interventional Oncology Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Interventional Oncology Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Interventional Oncology Market Size by Type (2016-2027)
    8.3 Asia-Pacific Interventional Oncology Market Size by Application
        8.3.1 Asia-Pacific Interventional Oncology Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Interventional Oncology Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Interventional Oncology Market Size by Application (2016-2027)
    8.4 Asia-Pacific Interventional Oncology Market Size by Region
        8.4.1 Asia-Pacific Interventional Oncology Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Interventional Oncology Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Interventional Oncology Market Size (2016-2027)
    9.2 Latin America Interventional Oncology Market Size by Type
        9.2.1 Latin America Interventional Oncology Market Size by Type (2016-2021)
        9.2.2 Latin America Interventional Oncology Market Size by Type (2022-2027)
        9.2.3 Latin America Interventional Oncology Market Size by Type (2016-2027)
    9.3 Latin America Interventional Oncology Market Size by Application
        9.3.1 Latin America Interventional Oncology Market Size by Application (2016-2021)
        9.3.2 Latin America Interventional Oncology Market Size by Application (2022-2027)
        9.3.3 Latin America Interventional Oncology Market Size by Application (2016-2027)
    9.4 Latin America Interventional Oncology Market Size by Country
        9.4.1 Latin America Interventional Oncology Market Size by Country (2016-2021)
        9.4.2 Latin America Interventional Oncology Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Interventional Oncology Market Size (2016-2027)
    10.2 Middle East & Africa Interventional Oncology Market Size by Type
        10.2.1 Middle East & Africa Interventional Oncology Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Interventional Oncology Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Interventional Oncology Market Size by Type (2016-2027)
    10.3 Middle East & Africa Interventional Oncology Market Size by Application
        10.3.1 Middle East & Africa Interventional Oncology Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Interventional Oncology Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Interventional Oncology Market Size by Application (2016-2027)
    10.4 Middle East & Africa Interventional Oncology Market Size by Country
        10.4.1 Middle East & Africa Interventional Oncology Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Interventional Oncology Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Boston Scientific
        11.1.1 Boston Scientific Company Details
        11.1.2 Boston Scientific Business Overview
        11.1.3 Boston Scientific Interventional Oncology Introduction
        11.1.4 Boston Scientific Revenue in Interventional Oncology Business (2016-2021)
        11.1.5 Boston Scientific Recent Development
    11.2 BTG
        11.2.1 BTG Company Details
        11.2.2 BTG Business Overview
        11.2.3 BTG Interventional Oncology Introduction
        11.2.4 BTG Revenue in Interventional Oncology Business (2016-2021)
        11.2.5 BTG Recent Development
    11.3 Medtronic
        11.3.1 Medtronic Company Details
        11.3.2 Medtronic Business Overview
        11.3.3 Medtronic Interventional Oncology Introduction
        11.3.4 Medtronic Revenue in Interventional Oncology Business (2016-2021)
        11.3.5 Medtronic Recent Development
    11.4 Merit Medical
        11.4.1 Merit Medical Company Details
        11.4.2 Merit Medical Business Overview
        11.4.3 Merit Medical Interventional Oncology Introduction
        11.4.4 Merit Medical Revenue in Interventional Oncology Business (2016-2021)
        11.4.5 Merit Medical Recent Development
    11.5 Terumo
        11.5.1 Terumo Company Details
        11.5.2 Terumo Business Overview
        11.5.3 Terumo Interventional Oncology Introduction
        11.5.4 Terumo Revenue in Interventional Oncology Business (2016-2021)
        11.5.5 Terumo Recent Development
    11.6 Accuray
        11.6.1 Accuray Company Details
        11.6.2 Accuray Business Overview
        11.6.3 Accuray Interventional Oncology Introduction
        11.6.4 Accuray Revenue in Interventional Oncology Business (2016-2021)
        11.6.5 Accuray Recent Development
    11.7 Alpinion Medical Systems
        11.7.1 Alpinion Medical Systems Company Details
        11.7.2 Alpinion Medical Systems Business Overview
        11.7.3 Alpinion Medical Systems Interventional Oncology Introduction
        11.7.4 Alpinion Medical Systems Revenue in Interventional Oncology Business (2016-2021)
        11.7.5 Alpinion Medical Systems Recent Development
    11.8 Angiodynamics
        11.8.1 Angiodynamics Company Details
        11.8.2 Angiodynamics Business Overview
        11.8.3 Angiodynamics Interventional Oncology Introduction
        11.8.4 Angiodynamics Revenue in Interventional Oncology Business (2016-2021)
        11.8.5 Angiodynamics Recent Development
    11.9 Atricure
        11.9.1 Atricure Company Details
        11.9.2 Atricure Business Overview
        11.9.3 Atricure Interventional Oncology Introduction
        11.9.4 Atricure Revenue in Interventional Oncology Business (2016-2021)
        11.9.5 Atricure Recent Development
    11.10 Baylis Medical
        11.10.1 Baylis Medical Company Details
        11.10.2 Baylis Medical Business Overview
        11.10.3 Baylis Medical Interventional Oncology Introduction
        11.10.4 Baylis Medical Revenue in Interventional Oncology Business (2016-2021)
        11.10.5 Baylis Medical Recent Development
    11.11 Bovie Medical
        11.11.1 Bovie Medical Company Details
        11.11.2 Bovie Medical Business Overview
        11.11.3 Bovie Medical Interventional Oncology Introduction
        11.11.4 Bovie Medical Revenue in Interventional Oncology Business (2016-2021)
        11.11.5 Bovie Medical Recent Development
    11.12 Brainlab
        11.12.1 Brainlab Company Details
        11.12.2 Brainlab Business Overview
        11.12.3 Brainlab Interventional Oncology Introduction
        11.12.4 Brainlab Revenue in Interventional Oncology Business (2016-2021)
        11.12.5 Brainlab Recent Development
    11.13 Bsd Medical
        11.13.1 Bsd Medical Company Details
        11.13.2 Bsd Medical Business Overview
        11.13.3 Bsd Medical Interventional Oncology Introduction
        11.13.4 Bsd Medical Revenue in Interventional Oncology Business (2016-2021)
        11.13.5 Bsd Medical Recent Development
    11.14 C. R. Bard
        11.14.1 C. R. Bard Company Details
        11.14.2 C. R. Bard Business Overview
        11.14.3 C. R. Bard Interventional Oncology Introduction
        11.14.4 C. R. Bard Revenue in Interventional Oncology Business (2016-2021)
        11.14.5 C. R. Bard Recent Development
    11.15 C2 Therapeutics
        11.15.1 C2 Therapeutics Company Details
        11.15.2 C2 Therapeutics Business Overview
        11.15.3 C2 Therapeutics Interventional Oncology Introduction
        11.15.4 C2 Therapeutics Revenue in Interventional Oncology Business (2016-2021)
        11.15.5 C2 Therapeutics Recent Development
    11.16 Cardiofocus
        11.16.1 Cardiofocus Company Details
        11.16.2 Cardiofocus Business Overview
        11.16.3 Cardiofocus Interventional Oncology Introduction
        11.16.4 Cardiofocus Revenue in Interventional Oncology Business (2016-2021)
        11.16.5 Cardiofocus Recent Development
    11.17 Cook Medical
        11.17.1 Cook Medical Company Details
        11.17.2 Cook Medical Business Overview
        11.17.3 Cook Medical Interventional Oncology Introduction
        11.17.4 Cook Medical Revenue in Interventional Oncology Business (2016-2021)
        11.17.5 Cook Medical Recent Development
    11.18 Eckert And Ziegler Bebig
        11.18.1 Eckert And Ziegler Bebig Company Details
        11.18.2 Eckert And Ziegler Bebig Business Overview
        11.18.3 Eckert And Ziegler Bebig Interventional Oncology Introduction
        11.18.4 Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2016-2021)
        11.18.5 Eckert And Ziegler Bebig Recent Development
    11.18 Edap Tms
        11.25.1 Edap Tms Company Details
        11.25.2 Edap Tms Business Overview
        11.25.3 Edap Tms Interventional Oncology Introduction
        11.25.4 Edap Tms Revenue in Interventional Oncology Business (2016-2021)
        11.25.5 Edap Tms Recent Development
    11.20 Elekta
        11.20.1 Elekta Company Details
        11.20.2 Elekta Business Overview
        11.20.3 Elekta Interventional Oncology Introduction
        11.20.4 Elekta Revenue in Interventional Oncology Business (2016-2021)
        11.20.5 Elekta Recent Development
    11.21 Galil Medical
        11.21.1 Galil Medical Company Details
        11.21.2 Galil Medical Business Overview
        11.21.3 Galil Medical Interventional Oncology Introduction
        11.21.4 Galil Medical Revenue in Interventional Oncology Business (2016-2021)
        11.21.5 Galil Medical Recent Development
    11.22 Healthtronics
        11.22.1 Healthtronics Company Details
        11.22.2 Healthtronics Business Overview
        11.22.3 Healthtronics Interventional Oncology Introduction
        11.22.4 Healthtronics Revenue in Interventional Oncology Business (2016-2021)
        11.22.5 Healthtronics Recent Development
    11.23 Insightec
        11.23.1 Insightec Company Details
        11.23.2 Insightec Business Overview
        11.23.3 Insightec Interventional Oncology Introduction
        11.23.4 Insightec Revenue in Interventional Oncology Business (2016-2021)
        11.23.5 Insightec Recent Development
    11.24 Medwaves
        11.24.1 Medwaves Company Details
        11.24.2 Medwaves Business Overview
        11.24.3 Medwaves Interventional Oncology Introduction
        11.24.4 Medwaves Revenue in Interventional Oncology Business (2016-2021)
        11.24.5 Medwaves Recent Development
    11.25 Mermaid Medical
        11.25.1 Mermaid Medical Company Details
        11.25.2 Mermaid Medical Business Overview
        11.25.3 Mermaid Medical Interventional Oncology Introduction
        11.25.4 Mermaid Medical Revenue in Interventional Oncology Business (2016-2021)
        11.25.5 Mermaid Medical Recent Development
    11.26 Microsulis Medical
        11.26.1 Microsulis Medical Company Details
        11.26.2 Microsulis Medical Business Overview
        11.26.3 Microsulis Medical Interventional Oncology Introduction
        11.26.4 Microsulis Medical Revenue in Interventional Oncology Business (2016-2021)
        11.26.5 Microsulis Medical Recent Development
    11.27 Monteris Medical
        11.27.1 Monteris Medical Company Details
        11.27.2 Monteris Medical Business Overview
        11.27.3 Monteris Medical Interventional Oncology Introduction
        11.27.4 Monteris Medical Revenue in Interventional Oncology Business (2016-2021)
        11.27.5 Monteris Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Interventional Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Ablation Devices
    Table 3. Key Players of Embolization Devices
    Table 4. Key Players of Support Devices
    Table 5. Global Interventional Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Interventional Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Interventional Oncology Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Interventional Oncology Market Share by Regions (2016-2021)
    Table 9. Global Interventional Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Interventional Oncology Market Share by Regions (2022-2027)
    Table 11. Interventional Oncology Market Trends
    Table 12. Interventional Oncology Market Drivers
    Table 13. Interventional Oncology Market Challenges
    Table 14. Interventional Oncology Market Restraints
    Table 15. Global Interventional Oncology Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Interventional Oncology Market Share by Players (2016-2021)
    Table 17. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Oncology as of 2020)
    Table 18. Ranking of Global Top Interventional Oncology Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Interventional Oncology Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Interventional Oncology Product Solution and Service
    Table 22. Date of Enter into Interventional Oncology Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Interventional Oncology Revenue Market Share by Type (2016-2021)
    Table 26. Global Interventional Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Interventional Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Interventional Oncology Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Interventional Oncology Revenue Market Share by Application (2016-2021)
    Table 30. Global Interventional Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Interventional Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Interventional Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Interventional Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Interventional Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Interventional Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Interventional Oncology Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Interventional Oncology Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Interventional Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Interventional Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Interventional Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Interventional Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Boston Scientific Company Details
    Table 63. Boston Scientific Business Overview
    Table 64. Boston Scientific Interventional Oncology Product
    Table 65. Boston Scientific Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 66. Boston Scientific Recent Development
    Table 67. BTG Company Details
    Table 68. BTG Business Overview
    Table 69. BTG Interventional Oncology Product
    Table 70. BTG Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 71. BTG Recent Development
    Table 72. Medtronic Company Details
    Table 73. Medtronic Business Overview
    Table 74. Medtronic Interventional Oncology Product
    Table 75. Medtronic Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 76. Medtronic Recent Development
    Table 77. Merit Medical Company Details
    Table 78. Merit Medical Business Overview
    Table 79. Merit Medical Interventional Oncology Product
    Table 80. Merit Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 81. Merit Medical Recent Development
    Table 82. Terumo Company Details
    Table 83. Terumo Business Overview
    Table 84. Terumo Interventional Oncology Product
    Table 85. Terumo Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 86. Terumo Recent Development
    Table 87. Accuray Company Details
    Table 88. Accuray Business Overview
    Table 89. Accuray Interventional Oncology Product
    Table 90. Accuray Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 91. Accuray Recent Development
    Table 92. Alpinion Medical Systems Company Details
    Table 93. Alpinion Medical Systems Business Overview
    Table 94. Alpinion Medical Systems Interventional Oncology Product
    Table 95. Alpinion Medical Systems Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 96. Alpinion Medical Systems Recent Development
    Table 97. Angiodynamics Company Details
    Table 98. Angiodynamics Business Overview
    Table 99. Angiodynamics Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 100. Angiodynamics Recent Development
    Table 101. Atricure Company Details
    Table 102. Atricure Business Overview
    Table 103. Atricure Interventional Oncology Product
    Table 104. Atricure Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 105. Atricure Recent Development
    Table 106. Baylis Medical Company Details
    Table 107. Baylis Medical Business Overview
    Table 108. Baylis Medical Interventional Oncology Product
    Table 109. Baylis Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 110. Baylis Medical Recent Development
    Table 111. Bovie Medical Company Details
    Table 112. Bovie Medical Business Overview
    Table 113. Bovie Medical Interventional Oncology Product
    Table 114. Bovie Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 115. Bovie Medical Recent Development
    Table 116. Brainlab Company Details
    Table 117. Brainlab Business Overview
    Table 118. Brainlab Interventional Oncology Product
    Table 119. Brainlab Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 120. Brainlab Recent Development
    Table 121. Bsd Medical Company Details
    Table 122. Bsd Medical Business Overview
    Table 123. Bsd Medical Interventional Oncology Product
    Table 124. Bsd Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 125. Bsd Medical Recent Development
    Table 126. C. R. Bard Company Details
    Table 127. C. R. Bard Business Overview
    Table 128. C. R. Bard Interventional Oncology Product
    Table 129. C. R. Bard Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 130. C. R. Bard Recent Development
    Table 131. C2 Therapeutics Company Details
    Table 132. C2 Therapeutics Business Overview
    Table 133. C2 Therapeutics Interventional Oncology Product
    Table 134. C2 Therapeutics Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 135. C2 Therapeutics Recent Development
    Table 136. Cardiofocus Company Details
    Table 137. Cardiofocus Business Overview
    Table 138. Cardiofocus Interventional Oncology Product
    Table 139. Cardiofocus Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 140. Cardiofocus Recent Development
    Table 141. Cook Medical Company Details
    Table 142. Cook Medical Business Overview
    Table 143. Cook Medical Interventional Oncology Product
    Table 144. Cook Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 145. Cook Medical Recent Development
    Table 146. Eckert And Ziegler Bebig Company Details
    Table 147. Eckert And Ziegler Bebig Business Overview
    Table 148. Eckert And Ziegler Bebig Interventional Oncology Product
    Table 149. Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 150. Eckert And Ziegler Bebig Recent Development
    Table 151. Edap Tms Company Details
    Table 152. Edap Tms Business Overview
    Table 153. Edap Tms Interventional Oncology Product
    Table 154. Edap Tms Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 155. Edap Tms Recent Development
    Table 156. Elekta Company Details
    Table 157. Elekta Business Overview
    Table 158. Elekta Interventional Oncology Product
    Table 159. Elekta Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 160. Elekta Recent Development
    Table 161. Galil Medical Company Details
    Table 162. Galil Medical Business Overview
    Table 163. Galil Medical Interventional Oncology Product
    Table 164. Galil Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 165. Galil Medical Recent Development
    Table 166. Healthtronics Company Details
    Table 167. Healthtronics Business Overview
    Table 168. Healthtronics Interventional Oncology Product
    Table 169. Healthtronics Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 170. Healthtronics Recent Development
    Table 171. Insightec Company Details
    Table 172. Insightec Business Overview
    Table 173. Insightec Interventional Oncology Product
    Table 174. Insightec Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 175. Insightec Recent Development
    Table 176. Medwaves Company Details
    Table 177. Medwaves Business Overview
    Table 178. Medwaves Interventional OncologyProduct
    Table 179. Medwaves Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 180. Medwaves Recent Development
    Table 181. Mermaid Medical Company Details
    Table 182. Mermaid Medical Business Overview
    Table 183. Mermaid Medical Interventional Oncology Product
    Table 184. Mermaid Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 185. Mermaid Medical Recent Development
    Table 186. Microsulis Medical Company Details
    Table 187. Microsulis Medical Business Overview
    Table 188. Microsulis Medical Interventional Oncology Product
    Table 189. Microsulis Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 190. Microsulis Medical Recent Development
    Table 191. Monteris Medical Company Details
    Table 192. Monteris Medical Business Overview
    Table 193. Monteris Medical Interventional Oncology Product
    Table 194. Monteris Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
    Table 195. Monteris Medical Recent Development
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Interventional Oncology Market Share by Type: 2020 VS 2027
    Figure 2. Ablation Devices Features
    Figure 3. Embolization Devices Features
    Figure 4. Support Devices Features
    Figure 5. Global Interventional Oncology Market Share by Application: 2020 VS 2027
    Figure 6. Liver Cancer Case Studies
    Figure 7. Lung Cancer Case Studies
    Figure 8. Kidney Cancer Case Studies
    Figure 9. Bone Cancer Case Studies
    Figure 10. Breast Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Pancreatic Cancer Case Studies
    Figure 13. Interventional Oncology Report Years Considered
    Figure 14. Global Interventional Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global Interventional Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Interventional Oncology Market Share by Regions: 2020 VS 2027
    Figure 17. Global Interventional Oncology Market Share by Regions (2022-2027)
    Figure 18. Global Interventional Oncology Market Share by Players in 2020
    Figure 19. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Oncology as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by Interventional Oncology Revenue in 2020
    Figure 21. Global Interventional Oncology Revenue Market Share by Type (2016-2021)
    Figure 22. Global Interventional Oncology Revenue Market Share by Type (2022-2027)
    Figure 23. North America Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America Interventional Oncology Market Share by Type (2016-2027)
    Figure 25. North America Interventional Oncology Market Share by Application (2016-2027)
    Figure 26. North America Interventional Oncology Market Share by Country (2016-2027)
    Figure 27. United States Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Interventional Oncology Market Share by Type (2016-2027)
    Figure 31. Europe Interventional Oncology Market Share by Application (2016-2027)
    Figure 32. Europe Interventional Oncology Market Share by Country (2016-2027)
    Figure 33. Germany Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Interventional Oncology Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific Interventional Oncology Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific Interventional Oncology Market Share by Region (2016-2027)
    Figure 43. China Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Interventional Oncology Market Share by Type (2016-2027)
    Figure 51. Latin America Interventional Oncology Market Share by Application (2016-2027)
    Figure 52. Latin America Interventional Oncology Market Share by Country (2016-2027)
    Figure 53. Mexico Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Interventional Oncology Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa Interventional Oncology Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa Interventional Oncology Market Share by Country (2016-2027)
    Figure 59. Turkey Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Boston Scientific Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 63. BTG Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 64. Medtronic Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 65. Merit Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 66. Terumo Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 67. Accuray Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 68. Alpinion Medical Systems Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 69. Angiodynamics Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 70. Atricure Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 71. Baylis Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 72. Bovie Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 73. Brainlab Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 74. Bsd Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 75. C. R. Bard Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 76. C2 Therapeutics Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 77. Cardiofocus Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 78. Cook Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 79. Eckert And Ziegler Bebig Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 80. Edap Tms Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 81. Elekta Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 82. Galil Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 83. Healthtronics Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 84. Insightec Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 85. Medwaves Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 86. Mermaid Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 87. Microsulis Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 88. Monteris Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Frequently Asked Questions
Interventional Oncology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Interventional Oncology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Interventional Oncology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

In-vehicle Apps

Driven by the demand for more connected vehicles, in-car entertainment is getting more and more s ... Read More